Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients
Phase 3
Not yet recruiting
- Conditions
- Ureter Injury
- Interventions
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Prove pharm
- Target Recruit Count
- 18
- Registration Number
- NCT06448143
Indigotindisulfonate Sodium Injection, USP As an Aid in the Determination of Ureteral Patency in Patient's with Renal Impairment
Phase 4
Recruiting
- Conditions
- Ureter Injury
- Interventions
- Other: Saline Injection 0.9%
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Prove pharm
- Target Recruit Count
- 48
- Registration Number
- NCT06085183
- Locations
- 🇺🇸
Albany Medical Center, Albany, New York, United States
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
Phase 4
Recruiting
- Conditions
- Ureter Injury
- Interventions
- Other: Saline injection 0.9%
- First Posted Date
- 2023-09-26
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Prove pharm
- Target Recruit Count
- 116
- Registration Number
- NCT06054880
- Locations
- 🇺🇸
Albany Medical Center, Albany, New York, United States
3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency
Phase 3
Completed
- Conditions
- Ureter Injury
- Interventions
- Drug: 3,3'-Dioxo-2,2'-bisindolylidene-5,5'-disulfonate disodium 0.8%Drug: Saline spray
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Prove pharm
- Target Recruit Count
- 121
- Registration Number
- NCT04228445
- Locations
- 🇺🇸
Adult and Pediatric Urology, Omaha, Nebraska, United States
© Copyright 2025. All Rights Reserved by MedPath